Notice: Undefined offset: 0 in /usr2/unibs/application/modules/live-market/controllers/CompanyController.php on line 43
Morepen Laboratories Share Price : Live NSE/BSE Stock Price Today
You are here » Home » Companies ยป Company Overview » Morepen Laboratories Ltd

Morepen Laboratories Ltd.

BSE: 500288 Sector: Health care
NSE: MOREPENLAB ISIN Code: INE083A01026
BSE 00:00 | 24 Apr 2020 Morepen Laboratories Ltd is not traded on BSE in the last 30 days
NSE 05:30 | 01 Jan 1970 Morepen Laboratories Ltd is not traded on NSE in the last 30 days

Notice: Undefined property: stdClass::$market_capital_for_nse in /usr2/unibs/application/modules/live-market/views/scripts/company/bs-new-bse-nse-block.php on line 17
OPEN 20.00
PREVIOUS CLOSE 19.43
VOLUME 1955276
52-Week high 24.00
52-Week low 7.21
P/E 26.00
Mkt Cap.(Rs cr) 830
Buy Price 18.48
Buy Qty 658.00
Sell Price 18.46
Sell Qty 5382.00
OPEN 20.00
CLOSE 19.43
VOLUME 1955276
52-Week high 24.00
52-Week low 7.21
P/E 26.00
Mkt Cap.(Rs cr) 830
Buy Price 18.48
Buy Qty 658.00
Sell Price 18.46
Sell Qty 5382.00

About Morepen Laboratories Ltd.

Morepen Laboratories Ltd

Morepen Laboratories Limited is an India-based pharmaceutical company. Its products include Loratadine, Montelukast Sodium, Atorvastatin Calcium and Sultamicillin. The company markets formulation products in various therapeutic categories, such as antibiotics, gastrointestinal, respiratory, analgesic, antiallergic and neuropsychiatry with brands, such as Saltum, Saltumax, Cefpopen, Cefpen-S, Dom-D...> More

Morepen Laboratories Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   830
EPS - TTM () [*S] 0.71
P/E Ratio (X) [*S] 26.00
Face Value ()   2
Latest Dividend (%)   -
Latest Dividend Date -
Dividend Yield (%) 0.00
Book Value / Share () [*S] 6.43
P/B Ratio () [*S] 2.87
[*C] Consolidated     [*S] Standalone    

Morepen Laboratories Ltd - Financial Results

Particulars ( cr) Dec 2019 Dec 2018 % Chg
Net Sales 230.06 212.16 8.44
Other Income 4.6 2.43 89.3
Total Income 234.66 214.59 9.35
Total Expenses 214.75 195.32 9.95
Operating Profit 19.91 19.27 3.32
Net Profit 10.82 8.91 21.44
Equity Capital 89.96 89.96 -
> More on Morepen Laboratories Ltd Financials Results

Morepen Laboratories Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Hester Bios 1137.40 5.93 967.93
Panacea Biotec 146.25 10.09 896.51
Marksans Pharma 20.61 -3.38 843.57
Morepen Labs. 18.46 -4.99 830.42
Fermenta Biotec. 244.60 -0.53 720.10
TTK Healthcare 451.00 -0.22 637.26
Neuland Labs. 401.85 1.91 515.57
> More on Morepen Laboratories Ltd Peer Group

Morepen Laboratories Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 34.54
Banks/FIs 0.43
FIIs 0.74
Insurance 4.82
Mutual Funds 0.00
Indian Public 41.07
Custodians 0.00
Other 9.84
> More on Morepen Laboratories Ltd Share Holding Pattern

Morepen Laboratories Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week 22.66% 22.26% -0.83% -1.21%
1 Month 138.81% 138.96% 17.44% 17.35%
3 Month 20.26% 19.87% -24.72% -25.26%
6 Month 15.38% 15.00% -19.72% -20.96%
1 Year 7.64% 6.98% -19.79% -21.93%
3 Year -11.89% -12.17% 5.64% -0.69%

Morepen Laboratories Ltd - STOCK STRENGTH

Today's Low/High 18.46
20.00
Week Low/High 14.50
20.00
Month Low/High 7.50
20.00
YEAR Low/High 7.21
24.00
All TIME Low/High 2.05
234.00